Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in FBIO — Fortress Biotech, Inc.

CIK 1595888 NEW YORK, NY
Back to FBIO Full portfolio

Position in FBIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$77,766
-$36,439 QoQ
Shares Held
25,414
-37.9% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 55 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FBIO Over Time

Shares Held

Position Value (USD)

Derivatives in FBIO

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$93,024
PutShares
30,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. FBIO ranks #214 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in FBIO

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $93,024 30,400
2026-06-30 $77,766 25,414
2026-03-31 $114,205 40,934
2025-12-31 $336,423 91,919
2025-12-31 $62,952 17,200
2025-09-30 $270,461 73,098
2024-12-31 $69,342 34,159
2023-12-31 $84,758 28,159
2023-09-30 $17,348 59,822
2020-12-31 $45,023 14,203
2020-06-30 $325,718 121,537
2020-03-31 $116,894 61,849